Navigation Links
Zimmer Biomet Prices Offering of Euro-Denominated Senior Notes
Date:12/6/2016

WARSAW, Ind., Dec. 6, 2016 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) (the "Company") today announced that it has priced an offering of €500.0 million principal amount of its 1.414% senior unsecured notes due 2022 and €500.0 million principal amount of its 2.425% senior unsecured notes due 2026.

The closing of the offering is expected to occur on December 13, 2016, subject to the satisfaction of customary closing conditions.  The notes will pay interest on an annual basis.

The Company intends to use the net proceeds from the sale of the notes to pay for the outstanding senior notes of the Company that it accepts for purchase in the cash tender offers commenced by the Company on November 21, 2016 and, if any net proceeds remain after such use, the Company intends to repay other U.S. dollar denominated indebtedness.

The joint book-running managers for the offering are BNP Paribas, HSBC Bank plc and RBC Europe Limited.

The Company has filed a registration statement (including a base prospectus) and a preliminary prospectus supplement with the U.S. Securities and Exchange Commission (the "SEC") for the offering to which this press release relates. Before you invest, you should read the preliminary prospectus supplement, the final prospectus supplement (when available), and the accompanying base prospectus in that registration statement and other documents the Company has filed with the SEC for more complete information about the Company and this offering. You may obtain these documents for free by visiting EDGAR on the SEC's website at www.sec.gov. Alternatively, the Company, any underwriter or any dealer participating in the offering will arrange to send you the preliminary prospectus supplement, the final prospectus supplement (when available), and the accompanying base prospectus if you request it by calling BNP Paribas toll-free at 1-800-854-5674, HSBC Bank plc toll-free at 1-866-811-8049 and RBC Europe Limited toll-free at 1-866-375-6829.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy any securities, nor will there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

This communication contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 regarding the closing of the offering of the senior notes and the Company's intended use of proceeds. Forward-looking statements may be identified by the use of forward-looking terms such as "may," "will," "expects," "believes," "anticipates," "plans," "estimates," "projects," "assumes," "guides," "targets," "forecasts," and "seeks" or the negatives of such terms or other variations on such terms or comparable terminology. Such statements are based upon the current beliefs and expectations of management and are subject to significant risks and uncertainties that could cause actual outcomes and results to differ materially. For a list and description of some of such risks and uncertainties, see the Company's filings with the SEC. These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in the Company's filings with the SEC. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be set forth in its periodic reports. Accordingly, such forward-looking statements speak only as of the date made. Readers of this communication are cautioned not to place undue reliance on these forward-looking statements, since, while management believes the assumptions on which the forward-looking statements are based are reasonable, there can be no assurance that these forward-looking statements will prove to be accurate. This cautionary statement is applicable to all forward-looking statements contained in this communication.

Logo - http://photos.prnewswire.com/prnh/20150624/225371LOGO

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/zimmer-biomet-prices-offering-of-euro-denominated-senior-notes-300373877.html


'/>"/>
SOURCE Zimmer Biomet Holdings, Inc.
Copyright©2016 PR Newswire.
All rights reserved


Related biology news :

1. Homeland Security Corporation (HSCC) Appoints New President with Biometrics and Access Control Solutions Expertise and Contacts
2. Global Biometrics and Border Control Award for DERMALOG
3. Global Biometric Systems Market Forecast & Opportunities, 2018
4. Integrated Biometrics Introduces Sherlock
5. Chiltern Announces The Promotion Of Alecia Barbee To VP, Global Biometrics
6. Fingerprint Cards (FPC) Demonstrates Fingerprint Biometric Touch Sensor for Microsoft Windows 8.1
7. Iris Biometrics Leader EyeLock Joins the FIDO Alliance to Help Identify More Secure Replacement for Usernames and Passwords
8. Biometric Authentication Provides Better Mobile Device Security, Heavy Reading Finds
9. New Technology Using Biometrics Detects If Security Guards Are Attacked, Injured Or Killed
10. Face and Voice Biometrics - Global Strategic Business Report
11. Neurotechnology Announces MegaMatcher Accelerator 6.0 High-speed, High-volume Multibiometric Identification Solution and Updates to Entire Biometric Product Line
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2018)... ... November 19, 2018 , ... SF Bay Cosmetic Body ... first and only non-invasive buttock lift procedure, with no injections necessary! Utilizing HIFEM® ... and firm the buttocks to provide a safe and completely non-invasive alternative to ...
(Date:11/16/2018)... WASHINGTON (PRWEB) , ... November 16, 2018 , ... ... It is called All Things Chemical™ and it will engage listeners in ... the law and business issues surrounding chemicals. B&C’s talented team of lawyers, scientists, ...
(Date:11/15/2018)... ... November 15, 2018 , ... Firmex today released new research ... surveyed over 480 investment bankers and M&A advisors worldwide to compile the third annual ... on the key findings in the report. , Highlights in the 2018-19 Report:, ...
Breaking Biology News(10 mins):
(Date:11/13/2018)... ... November 12, 2018 , ... AseptiScope(TM), Inc. announces ... large U.S. studies, published last week, confirm pose a significant health risk. ... (AJIC) conclude that stethoscopes are often improperly or rarely disinfected. In the AJIC ...
(Date:11/13/2018)... ... November 13, 2018 , ... , Park Systems, world ... China. With the increasingly growing demand for AFM technology in China, Park Systems has ... by opening an office in Beijing equipped with Park AFM. , The Grand Opening ...
(Date:11/9/2018)... ... November 08, 2018 , ... ... Valenzuela, PhD, co-Founder, Chief Executive Officer and President of Andes Biotechnologies, to its ... the world, Dr. Valenzuela brings to uBiome expertise on the genetic studies of ...
(Date:11/7/2018)... ... November 07, 2018 , ... Since September of ... increase awareness of the adult tissue stem cell counting problem in stem cell ... company is intensifying this effort with new educational publications and presentations at clinical ...
Breaking Biology Technology: